Philippines: Second Health System Enhancement to Address and Limit COVID-19 under the Asia Pacific Vaccine Access Facility - Additional Financing
The additional financing of the Second Health System Enhancement to Address and Limit
COVID-19 under the Asia Pacific Vaccine Access Facility (HEAL2-AF) builds on the original
project and will expand the Philippines procurement and deployment of coronavirus disease
(COVID-19) vaccines. It will support the governments procurement of at least 40 million additional
doses of COVID-19 vaccines for eligible children, and third and booster shots for the wider
population.2 The HEAL2-AF complements the Asian Development Bank (ADB) Health System
Enhancement to Address and Limit COVID-19 (HEAL) project, which supports the government's
COVID-19 response.
Project Details
-
Project Officer
Tanaka, Sakiko
Southeast Asia Department
Request for information -
Approval Date
13 December 2021 -
Country
Philippines -
Sector
- Health
Related Projects
| Project Name | Second Health System Enhancement to Address and Limit COVID-19 under the Asia Pacific Vaccine Access Facility - Additional Financing | ||||||||
| Project Number | 54171-004 | ||||||||
| Country | Philippines |
||||||||
| Project Status | Approved | ||||||||
| Project Type / Modality of Assistance | Loan |
||||||||
| Source of Funding / Amount |
|
||||||||
| Strategic Agendas | Inclusive economic growth Regional integration |
||||||||
| Drivers of Change | Gender Equity and Mainstreaming Partnerships |
||||||||
| Sector / Subsector | Health / Disease control of communicable disease |
||||||||
| Gender Equity and Mainstreaming | Effective gender mainstreaming | ||||||||
| Description | The additional financing of the Second Health System Enhancement to Address and Limit COVID-19 under the Asia Pacific Vaccine Access Facility (HEAL2-AF) builds on the original project and will expand the Philippines procurement and deployment of coronavirus disease (COVID-19) vaccines. It will support the governments procurement of at least 40 million additional doses of COVID-19 vaccines for eligible children, and third and booster shots for the wider population.2 The HEAL2-AF complements the Asian Development Bank (ADB) Health System Enhancement to Address and Limit COVID-19 (HEAL) project, which supports the government's COVID-19 response. |
||||||||
| Project Rationale and Linkage to Country/Regional Strategy | On 11 March 2021, ADB approved a regular loan of $400 million for HEAL2 to be financed from its ordinary capital resources.4 HEAL2 is cofinanced by AIIB with a loan of $300 million, partially administered by ADB. HEAL2 provided the Government of the Philippines with timely financing for procurement of safe and effective vaccines and related logistics, based on an agreed list of eligible expenditures. In total, with a major change in scope of HEAL (footnote 3), ADB has provided $425 million for COVID-19 vaccine procurement and deployment. |
||||||||
| Impact | Impacts the Project is Aligned with Health system performance in addressing public health outbreaks improved (National Objectives for Health, Philippines 2017 2022)a Protection of the public and reduction of COVID-19-related morbidity and mortality fostered (National COVID-19 Vaccine Roadmap)b Economic growth and citizens' confidence restored (ADB's Support to Enhance COVID-19 Vaccine)c |
||||||||
| Project Outcome | |
|---|---|
| Description of Outcome | Priority populations vaccinated against COVID-19. |
| Progress Toward Outcome | |
| Implementation Progress | |
| Description of Project Outputs | 1. COVID-19 vaccines efficiently and effectively delivered. |
| Status of Implementation Progress (Outputs, Activities, and Issues) | |
| Geographical Location | Nation-wide |
| Safeguard Categories | |
|---|---|
| Environment | C |
| Involuntary Resettlement | C |
| Indigenous Peoples | C |
| Summary of Environmental and Social Aspects | |
|---|---|
| Environmental Aspects | |
| Involuntary Resettlement | |
| Indigenous Peoples | |
| Stakeholder Communication, Participation, and Consultation | |
| During Project Design | |
| During Project Implementation | |
| Responsible ADB Officer | Tanaka, Sakiko |
| Responsible ADB Department | Southeast Asia Department |
| Responsible ADB Division | Human and Social Development Division, SERD |
| Executing Agencies |
Department of Health Dr. Edilberto Fernandez [email protected] Tayuman Street Sta. Cruz, Manila Philippines |
| Timetable | |
|---|---|
| Concept Clearance | - |
| Fact Finding | 21 Sep 2021 to 24 Sep 2021 |
| MRM | 22 Oct 2021 |
| Approval | 13 Dec 2021 |
| Last Review Mission | - |
| Last PDS Update | 13 Dec 2021 |
Loan 4163-PHI
| Milestones | |||||
|---|---|---|---|---|---|
| Approval | Signing Date | Effectivity Date | Closing | ||
| Original | Revised | Actual | |||
| 13 Dec 2021 | 14 Dec 2021 | - | 30 Sep 2024 | - | - |
| Financing Plan | Loan Utilization | ||||
|---|---|---|---|---|---|
| Total (Amount in US$ million) | Date | ADB | Others | Net Percentage | |
| Project Cost | 299.37 | Cumulative Contract Awards | |||
| ADB | 250.00 | 10 Jan 2022 | 0.00 | 0.00 | 0% |
| Counterpart | 49.37 | Cumulative Disbursements | |||
| Cofinancing | 0.00 | 10 Jan 2022 | 0.00 | 0.00 | 0% |
Loan 8413-PHI
| Financing Plan | Loan Utilization | ||||
|---|---|---|---|---|---|
| Total (Amount in US$ million) | Date | ADB | Others | Net Percentage | |
| Project Cost | 250.00 | Cumulative Contract Awards | |||
| ADB | 0.00 | - | 0.00 | 0.00 | % |
| Counterpart | 0.00 | Cumulative Disbursements | |||
| Cofinancing | 250.00 | - | 0.00 | 0.00 | % |
Project Data Sheets (PDS) contain summary information on the project or program. Because the PDS is a work in progress, some information may not be included in its initial version but will be added as it becomes available. Information about proposed projects is tentative and indicative.
The Access to Information Policy (AIP) recognizes that transparency and accountability are essential to development effectiveness. It establishes the disclosure requirements for documents and information ADB produces or requires to be produced.
The Accountability Mechanism provides a forum where people adversely affected by ADB-assisted projects can voice and seek solutions to their problems and report alleged noncompliance of ADB's operational policies and procedures.
In preparing any country program or strategy, financing any project, or by making any designation of, or reference to, a particular territory or geographic area in this document, the Asian Development Bank does not intend to make any judgments as to the legal or other status of any territory or area.
| Title | Document Type | Document Date |
|---|---|---|
| Loan Agreement (Ordinary Operations) for Loan 4163-PHI: Second Health System Enhancement to Address and Limit COVID-19 under the Asia Pacific Vaccine Access Facility - Additional Financing | Loan Agreement (Ordinary Resources) | Dec 2021 |
| Second Health System Enhancement to Address and Limit COVID-19 under the Asia Pacific Vaccine Access Facility - Additional Financing: Project Administration Manual | Project/Program Administration Manual | Nov 2021 |
| Second Health System Enhancement to Address and Limit COVID-19 under the Asia Pacific Vaccine Access Facility - Additional Financing: Report and Recommendation of the President | Reports and Recommendations of the President | Nov 2021 |
| Second Health System Enhancement to Address and Limit COVID-19 under the Asia Pacific Vaccine Access Facility - Additional Financing: Procurement Plan | Procurement Plans | Nov 2021 |
Safeguard Documents See also: Safeguards
Safeguard documents provided at the time of project/facility approval may also be found in the list of linked documents provided with the Report and Recommendation of the President.
None currently available.
Evaluation Documents See also: Independent Evaluation
None currently available.
Related Publications
None currently available.
The Access to Information Policy (AIP) establishes the disclosure requirements for documents and information ADB produces or requires to be produced in its operations to facilitate stakeholder participation in ADB's decision-making. For more information, refer to the Safeguard Policy Statement, Operations Manual F1, and Operations Manual L3.
Requests for information may also be directed to the InfoUnit.
-
$250 Million ADB Loan to Help Boost COVID-19 Vaccine Supply in the Philippines
The Asian Development Bank has approved a $250 million loan to help the Philippine government secure additional COVID-19 vaccine supply to boost the health security of Filipinos and ensure a safe and steady economic recovery.
Tenders
No tenders for this project were found.
Contracts Awarded
No contracts awarded for this project were found
Procurement Plan
| Title | Document Type | Document Date |
|---|---|---|
| Second Health System Enhancement to Address and Limit COVID-19 under the Asia Pacific Vaccine Access Facility - Additional Financing: Procurement Plan | Procurement Plans | Nov 2021 |